APA aipamena

Yeboah, M., Papagregoriou, C., Jones, D. C., Chan, H. C., Hu, G., McPartlan, J. S., . . . Roghanian, A. (2020). LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation. JCI Insight.

Chicago Style aipamena

Yeboah, Muchaala, et al. "LILRB3 (ILT5) Is a Myeloid Cell Checkpoint That Elicits Profound Immunomodulation." JCI Insight 2020.

MLA aipamena

Yeboah, Muchaala, et al. "LILRB3 (ILT5) Is a Myeloid Cell Checkpoint That Elicits Profound Immunomodulation." JCI Insight 2020.